Published in Health Business Week, March 11th, 2005
As with the company's two most recent rounds of financing, Boston Millennia Partners participated in the latest round by investing in half the round. With this latest offering, Arthrosurface has closed on an aggregate of $22 million of equity financing to date.
"This latest round of funding will allow us to complete development and achieve inventory positions on our second generation of products," said Steve Ek, COO. "We are most pleased with our patient outcomes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.